Centessa Pharmaceuticals plc Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 15.0M | 0 | 0 | 0 |
| Cost of Goods Sold | 239K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -239K | 0 | 0 | 0 | 15.0M | 0 | 0 | 0 |
| R&D Expenses | 59.9M | 54.5M | 41.6M | 42.7M | 33.4M | 60.9M | 33.9M | 32.8M |
| Operating Expenses | 79.8M | 68.5M | 53.8M | 54.7M | 45.8M | 74.6M | 46.4M | 44.0M |
| Operating Income | -79.8M | -68.5M | -53.8M | -54.7M | -30.8M | -74.6M | -46.4M | -44.0M |
| Other Income / Gains | 1.4M | 1.8M | -935K | 5.1M | 6.0M | -35.7M | 4.4M | 869K |
| Net Income | -79.2M | -66.2M | -54.9M | -50.3M | -26.1M | -111.3M | -42.6M | -43.8M |
| EPS (Diluted) | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 | -0.84 | -0.37 | -0.40 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 1.00 | 0 | 0 | 0 |
| General And Administrative Expenses | 19.9M | 14.0M | 12.2M | 11.9M | 12.3M | 13.7M | 12.5M | 11.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 19.9M | 14.0M | 12.2M | 11.9M | 12.3M | 13.7M | 12.5M | 11.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 79.6M | 68.5M | 53.8M | 54.7M | 45.8M | 74.6M | 46.4M | 44.0M |
| Interest Income | 5.1M | 4.5M | 3.8M | 4.4M | 7.9M | 4.8M | 3.3M | 3.2M |
| Interest Expense | 2.7M | 2.8M | 2.9M | 2.9M | 2.9M | 2.5M | 2.6M | 2.5M |
| Depreciation And Amortization | 239K | -680K | 237K | 226K | 217K | 230K | 236K | 236K |
| Ebitda | -79.8M | -88.0M | -51.6M | -46.5M | -21.6M | -107.6M | -39.2M | -40.4M |
| Ebitdaratio | 0 | 0 | 0 | 0 | -1.443 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | -2.052 | 0 | 0 | 0 |
| Income Before Tax | -78.4M | -66.7M | -54.7M | -49.6M | -24.7M | -110.3M | -42.0M | -43.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | -1.649 | 0 | 0 | 0 |
| Income Tax Expense | 850K | -522K | 166K | 778K | 1.4M | 1.1M | 608K | 705K |
| Net Income Ratio | 0 | 0 | 0 | 0 | -1.742 | 0 | 0 | 0 |
| Epsdiluted | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 | -0.84 | -0.37 | -0.40 |
| Weighted Average Shs Out | 153.5M | 135.7M | 134.2M | 133.7M | 133.0M | 132.1M | 116.3M | 109.5M |
| Weighted Average Shs Out Dil | 153.5M | 135.7M | 134.2M | 133.7M | 133.0M | 132.1M | 116.3M | 109.5M |